Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants
Clinical trial NCT03589768 · COMPLETED
Trial details
- NCT number
- NCT03589768
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2020-07-01
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.